Back to Results
First PageMeta Content
Medison / Lipoplatin / Liposome / Lung cancer / Pharmaceutical industry / Non-small-cell lung carcinoma / Cisplatin / Chemistry / Alkylating antineoplastic agents / Medicine


PUBLIC PRESS RELEASE 11 JUNE, 2012 Pres s Releas e
Add to Reading List

Document Date: 2012-06-18 06:06:11

Open Document

File Size: 219,91 KB

Share Result on Facebook

City

Petach Tikva / Palo Alto / /

Company

REGULON GROUP Regulon Inc. / Medison Pharma Ltd. / /

Country

United States / Israel / /

Event

FDA Phase / Business Partnership / /

IndustryTerm

followup products / biopharmaceutical / niche pharmaceuticals / healthcare industry / healthcare markets / liposomal encapsulation successful product / healthcare cost savings / pharmaceutical products technology / diagnostic products / treatment of non-small cell lung cancer / /

MedicalCondition

tumor / tumors / NSCLC / non-small cell lung cancer / metastases / pancreatic cancer / /

Person

Teni Boulikas / /

Position

CEO / President and CEO / /

Product

cisplatin / LipoxalTM / LipoplatinTM / NSCLC / /

ProvinceOrState

California / /

Technology

pharmaceutical products technology / /

SocialTag